Warning: The NCBI web site requires JavaScript to function. more...
ESF-EMBO symposium: antiviral applications of RNA interference.
ter Brake O, Haasnoot J, Kurreck J, Berkhout B.
Retrovirology. 2008 Sep 18;5:81. No abstract available.
Related citations
RNA interference & inhibition of viruses.
Gadkari DA.
Indian J Med Res. 2005 Mar;121(3):147-50. Review. No abstract available.
RNA interference: a promising approach to antiviral therapy?
Silva JM, Hammond SM, Hannon GJ.
Trends Mol Med. 2002 Nov;8(11):505-8. No abstract available.
The potential of RNA interference-based therapies for viral infections.
Huang DD.
Curr HIV/AIDS Rep. 2008 Feb;5(1):33-9. Review.
Nucleic acids-based therapeutics in the battle against pathogenic viruses.
Haasnoot J, Berkhout B.
Handb Exp Pharmacol. 2009;(189):243-63. Review.
siRNAs: a new wave of RNA-based therapeutics.
Coburn GA, Cullen BR.
J Antimicrob Chemother. 2003 Apr;51(4):753-6. Epub 2003 Mar 13. Review. No abstract available.
Effective inhibition of hepatitis E virus replication in A549 cells and piglets by RNA interference (RNAi) targeting RNA-dependent RNA polymerase.
Huang F, Hua X, Yang S, Yuan C, Zhang W.
Antiviral Res. 2009 Sep;83(3):274-81. Epub 2009 Jul 1.
RNA interference: a multifaceted innate antiviral defense.
Kumar A.
Retrovirology. 2008 Feb 1;5:17. Review.
Design of LNA-modified siRNAs against the highly structured 5' UTR of coxsackievirus B3.
Dutkiewicz M, Grunert HP, Zeichhardt H, Lena SW, Wengel J, Kurreck J.
FEBS Lett. 2008 Sep 3;582(20):3061-6. Epub 2008 Aug 6.
RNA interference protects horse cells in vitro from infection with Equine Arteritis Virus.
Heinrich A, Riethmüller D, Gloger M, Schusser GF, Giese M, Ulbert S.
Antiviral Res. 2009 Mar;81(3):209-16. Epub 2008 Nov 11.
Development of interfering RNA agents to inhibit SARS-associated coronavirus infection and replication.
He ML, Zheng BJ, Chen Y, Wong KL, Huang JD, Lin MC, Yuen KY, Sung JJ, Kung HF.
Hong Kong Med J. 2009 Jun;15(3 Suppl 4):28-31. No abstract available.
Is RNA interference involved in intrinsic antiviral immunity in mammals?
Cullen BR.
Nat Immunol. 2006 Jun;7(6):563-7. Review.
RNA interference inhibits yellow fever virus replication in vitro and in vivo.
Pacca CC, Severino AA, Mondini A, Rahal P, D'avila SG, Cordeiro JA, Nogueira MC, Bronzoni RV, Nogueira ML.
Virus Genes. 2009 Apr;38(2):224-31. Epub 2009 Jan 25.
[RNA interference as antiviral strategy].
Neumann-Haefelin C, Blum HE, Thimme R.
Dtsch Med Wochenschr. 2008 Nov;133(46):2407-9. Epub 2008 Nov 4. Review. German.
Cholesterol paves the way for topically applied viricides.
Rossi JJ.
Cell Host Microbe. 2009 Jan 22;5(1):6-7.
Therapeutic applications of RNAi for silencing virus replication.
Tripp RA, Tompkins SM.
Methods Mol Biol. 2009;555:43-61.
[Antiviral action of sulfated polysaccharides].
Makarenkova ID, Besednova NN, Zaporozhets TS.
Antibiot Khimioter. 2009;54(1-2):56-62. Review. Russian.
Nucleic acid-based immune system: the antiviral potential of mammalian RNA silencing.
Gitlin L, Andino R.
J Virol. 2003 Jul;77(13):7159-65. Review. No abstract available.
Identification of small interfering RNAs which inhibit the replication of several Enterovirus 71 strains in China.
Wu Z, Yang F, Zhao R, Zhao L, Guo D, Jin Q.
J Virol Methods. 2009 Aug;159(2):233-8. Epub 2009 Apr 10.
RNA interference: from basic research to therapeutic applications.
Kurreck J.
Angew Chem Int Ed Engl. 2009;48(8):1378-98. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on